Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13180)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2025 (publication date) through Apr 18, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Liu T, Wang H, Zhao Y, Wang YX, Xing X, Gao P. Drug development for chronic hepatitis B functional cure: Recent progress. World J Hepatol 2025; 17(4): 105797 [PMID: 40308829 DOI: 10.4254/wjh.v17.i4.105797] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Liu T, Wang H, Zhao Y, Wang YX, Xing X, Gao P. Drug development for chronic hepatitis B functional cure: Recent progress. World J Hepatol 2025; 17(4): 105797 [PMID: 40308829 DOI: 10.4254/wjh.v17.i4.105797] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i4/105797.htm |
| Number | Citing Articles |
| 1 |
Yige Wang, Shuhan Tang, Pengyu Li, Yidan Sun, Yaqi Xu, Hao Li, HongYing Xu, Ying Wang, Hailong Zhang, Xianna Li, Zhigang Wang. Untargeted Metabolomic Study of the Anti‐HBV Effects of Erythrocentaurin In Vitro and In Vivo Using UPLC‐Q‐TOF/MS. Biomedical Chromatography 2026; 40(6) doi: 10.1002/bmc.70447
|
| 2 |
Fatemeh Sana Askari, Alireza Mohebbi. The dynamic states of hepatitis B virus capsid monomers under the impact of different class of capsid-assembly modulators. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-18339-6
|
| 3 |
Liba Sokolovska, Juris Jansons, Franco M. Buonaguro, Maria Isaguliants. Online Conference “Chronic Viral Infections and Cancer, Openings for Vaccines and Cure” VIRCAN2024, Monitoring the Progress. Vaccines 2025; 13(9): 940 doi: 10.3390/vaccines13090940
|
| 4 |
Chao Cui, Yu Sun, Kaiyue Zhang, Jingfei Shi, Kai Wang, Shuai Gao. Research Progress on the Mechanism and Targeted Intervention of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1)-Mediated “Inflammation-Apoptosis-Metabolism-Microcirculation” Regulatory Network in Hepatitis B-Associated Liver Failure. Drug Design, Development and Therapy 2026; : 1 doi: 10.2147/DDDT.S573597
|
| 5 |
Maxime Beretta, Ariel Mechaly, Cyril Planchais, Ahmed Haouz, Célia Caillet-Saguy, Nathan Szerman, Yada Aronthippaitoon, Marie-Noëlle Ungeheuer, Stanislas Pol, Catherine Gaudy-Graffin, Camille Sureau, Maryline Bourgine, Hugo Mouquet. In vivo efficacy of combined human broadly neutralizing antibodies against hepatitis B virus. Cell Reports 2025; 44(12): 116705 doi: 10.1016/j.celrep.2025.116705
|
| 6 |
Nadezhda A. Pechnikova, Maria Zafeiriou-Chatziefraimidou, Malamati Poimenidou, Chrysi Patsidou, Ioannis Iliadis, Yulia V. Ostankova, Alexey V. Yaremenko. mRNA vaccines for HBV: Mechanisms, preclinical advances, and therapeutic clinical progress. Molecular Therapy Nucleic Acids 2026; 37(1): 102819 doi: 10.1016/j.omtn.2025.102819
|
| 7 |
Prashant Tiwari, Istuti Saraswat, Jyoti Gupta. Insight into the Biology of Hepatitis B Virus and Recent Therapeutic Approaches. Current Microbiology 2026; 83(3) doi: 10.1007/s00284-026-04725-4
|
| 8 |
Ayman Elbehiry, Musaad Aldubaib. Hepatocyte-Targeted Drug Delivery Strategies for Chronic Hepatitis B: Overcoming Delivery Barriers Toward Functional Cure. Pharmaceutics 2026; 18(2): 212 doi: 10.3390/pharmaceutics18020212
|